Effects of probiotic supplementation in adult with atopic dermatitis: a systematic review with meta-analysis

Abstract

Abstract Background Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases. The effect of probiotic administration on the severity of AD in adults has shown inconsistent results. Objectives To determine the effectiveness of probiotic supplementation as a therapeutic tool for adult AD. Methods PubMed, Scopus and Embase were systematically searched to collect data from studies in which probiotics were administered to treat adult AD. Results Out of 413 publications, 9 papers were included in the meta-analysis. Significant differences in the ScORing Atopic Dermatitis tool favouring probiotics were observed [relative risk (RR) –5.93, 95% confidence interval (CI) –8.43 to –3.43]. Lactobacillus salivarius presented with largest effect size (RR –9.79, 95% CI –13.04 to –6.54), followed by L. acidophilus (RR –5.77, 95% CI –10.82 to –0.72) and L. plantarum (RR –3.76, 95% CI –6.36 to –1.16). No benefit was observed with L. fermentum. Based on the severity of AD, probiotics showed better results in people with moderate-to-severe AD (RR –9.12, 95% CI –12.17 to –6.08) than in individuals with mild disease (RR –2.67, 95% CI –4.67 to –0.66). Serum levels of IgE and eosinophil count remained significantly unchanged after the probiotic intervention (RR 0.25, 95% CI –0.10 to 0.60; RR –0.27, 95% CI –0.68 to 0.13, respectively). Conclusions Current evidence supports a role for some probiotics as a therapeutic tool for the treatment of adult AD, particularly in patients with severe AD. The efficacy of probiotics is strain specific, with L. salivarius and L. acidophilus having the largest clinical benefit. Such benefit is apparently independent of IgE levels and eosinophil count. Despite these encouraging results, the decrease in AD severity did not translate into a clinically meaningful better quality of life as assessed by the Dermatology Life Quality Index. There currently is not enough reliable data to reach conclusions about the optimal dose and duration for probiotic treatment.